James W. Mitchell
Keine laufenden Positionen mehr
Profil
Dr. James W.
Mitchell is Chief Operating Officer at TVAX Biomedical, Inc.
He received his undergraduate degree from Drury University and a doctorate degree from Iowa State University.
Ehemalige bekannte Positionen von James W. Mitchell
| Unternehmen | Position | Ende |
|---|---|---|
| TVAX BIOM | Geschäftsführer | - |
Ausbildung von James W. Mitchell
| Iowa State University | Doctorate Degree |
| Drury University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
